Dr. Dartois Joined PHRI in April 2012, with an academic appointment in the Department of Medicine at Rutgers, the State University of New Jersey. Initially trained as a molecular biologist, Dr Dartois comes with 7 years of experience in the pharmaceutical industry, acquired through her previous position as Pharmacology Unit Head at the Novartis Institute of Tropical Diseases in Singapore. Her current research interests include the pharmacokinetics and imaging of anti-tuberculosis drugs in pulmonary lesions, the molecular mechanisms driving intracellular accumulation of TB drugs in Mycobacetrium and in macrophages, and the optimization of predictive animal models and in vitro assays to study these questions.